Eduardo Vilar

8.9k citations

106 papers · 4.8k indexed · 2 hit papers · h-index 33

Oncology top 0.5%
Pathology and Forensic Medicine top 0.5%
Molecular Biology top 5%
Cancer Research top 1%
Epidemiology top 5%

Co-authors: Stephen B. Gruber Josep Tabernero Scott Kopetz Y. Nancy You Miguel A. Rodrı́guez-Bigas José Manuel Pérez-García Kyle Chang Cathy Eng
Topics: Genetic factors in colorectal cancer (65 papers)Cancer Genomics and Diagnostics (33 papers)Colorectal Cancer Treatments and Studies (29 papers)
Cited by: Oncology Pathology and Forensic Medicine Cancer Research
Journals: Proceedings of the National Academy of Sciences Angewandte Chemie International Edition Journal of Clinical Investigation
Partner nations: United States Spain Italy

In The Last Decade

Eduardo Vilar

99 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Microsatellite instability in colorectal cancer—the stable evidence

2010 734 citations Eduardo Vilar, Stephen B. Gruber profile →
Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer

2022 141 citations Eduardo Vilar et al. profile →

Peers

Countries citing papers authored by Eduardo Vilar

Since Specialization

Citations

This map shows the geographic impact of Eduardo Vilar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Vilar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Vilar more than expected).

Fields of papers citing papers by Eduardo Vilar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduardo Vilar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Vilar. The network helps show where Eduardo Vilar may publish in the future.

Co-authorship network of co-authors of Eduardo Vilar

This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo Vilar. A scholar is included among the top collaborators of Eduardo Vilar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo Vilar. Eduardo Vilar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Citrullinated ENO1 Vaccine Enhances PD-1 Blockade in Mice Implanted with Murine Triple-Negative Breast Cancer Cells 2025 ·Vaccines ·(unknown),(unknown),Yihui Chen,So‐Young Park,Jody V. Vykoukal,Johannes F. Fahrmann,Edwin J. Ostrin,Christopher R. Garrett,Rongzhang Dou,(unknown),(unknown),Jennifer B. Dennison,Eduardo Vilar,Banu Arun,Samir Hanash,Hiroyuki Katayama	0
2	Mutational and co-mutational landscape of early onset colorectal cancer 2025 ·Biomarkers ·(unknown),(unknown),(unknown),(unknown),Michael G. White,John Paul Shen,Eduardo Vilar,Christine M. Parseghian,(unknown),Van K. Morris,Ryan Huey,Michael J. Overman,Robert A. Wolff,Kanwal Raghav,Jason Willis,(unknown),Andy Futreal,Y. Nancy You,Scott Kopetz	6
3	638 Nous-209 vaccine induces shared neoantigen immunogenicity for cancer interception in healthy lynch syndrome carriers: results from phase Ib/II trial 2024 ·Regular and Young Investigator Award Abstracts ·Eduardo Vilar,Jason Willis,(unknown),Michael J. Hall,Marcia Cruz‐Correa,Gregory Idos,Selvi Thirumurthi,Guido Leoni,(unknown),Laura Antonucci,Sven Gogov,Wenli Dong,J. Jack Lee,Lana A. Vornik,Araceli García-González,Ellen Richmond,Asad Umar,Powel H. Brown,Luz M. Rodriguez,Elisa Scarselli	1
4	Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination 2023 ·Cancer Research Communications ·(unknown),Jane V. Thomas,Kaysia Ludford,Jason Willis,(unknown),Kanwal Raghav,Benny Johnson,Arvind Dasari,Bryan K. Kee,Christine M. Parseghian,Michael S. Lee,(unknown),Maria Pia Morelli,John Paul Shen,(unknown),Eduardo Vilar,Robert A. Wolff,Scott Kopetz,Michael J. Overman,Van K. Morris	4
5	The Cancer Moonshot Immuno-Oncology Translational Network at 5: accelerating cancer immunotherapies 2023 ·JNCI Journal of the National Cancer Institute ·Ananth Annapragada,Andrew G. Sikora,Himangi Marathe,(unknown),Michael Demetriou,Lawrence Fong,Jinming Gao,Donald Küfe,Zachary S. Morris,Eduardo Vilar,Elad Sharon,Alan D. Hutson,Kunle Odunsi	2
6	Human intestinal organoids from Cronkhite-Canada syndrome patients reveal link between serotonin and proliferation 2023 ·Journal of Clinical Investigation ·(unknown),(unknown),Amal Kambal,Hoa Nguyen‐Phuc,Sara C. Di Rienzi,Heather A. Danhof,(unknown),Linda A. Feagins,Nan Deng,Eduardo Vilar,Florencia McAllister,Cristian Coarfa,So‐Youn Min,Hyun Jung Kim,(unknown),Robert A. Britton,Mary K. Estes,Sarah E. Blutt	8
7	Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: a global clinical practice survey 2023 ·Frontiers in Oncology ·(unknown),Rachel Hodan,Linda Rodgers,Sanjeevani Arora,Francesc Balaguer,José G. Guillem,Joanne Jeter,Priyanka Kanth,Dan Li,David Liska,Joshua Melson,Kimberly Perez,Charité Ricker,Brian H. Shirts,Eduardo Vilar,Bryson W. Katona,Mev Dominguez–Valentin	6
8	Clinically Significant Metachronous Colorectal Pathology Detected Among Young-Onset Colorectal Cancer Survivors: Implications for Post-Resection Surveillance Guidelines 2022 ·Gastroenterology ·Oliver Peacock,Eduardo Vilar,(unknown),Selvi Thirumurthi,George J. Chang,Y. Nancy You	4
9	Resistance Mechanisms to Anti–Epidermal Growth Factor Receptor Therapy in RAS/RAF Wild-Type Colorectal Cancer Vary by Regimen and Line of Therapy 2022 ·Journal of Clinical Oncology ·Christine M. Parseghian,Ryan Sun,(unknown),Stefania Napolitano,(unknown),(unknown),Jason Willis,(unknown),Kanwal Raghav,Van K. Morris,John Paul Shen,(unknown),Alexey V. Sorokin,Preeti Kanikarla Marie,Eduardo Vilar,Marko Rehn,Agnes Ang,Teresa Troiani,Scott Kopetz	41
10	Patterns of germline and somatic testing after universal tumor screening for Lynch syndrome: A clinical practice survey of active members of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer 2022 ·Journal of Genetic Counseling ·Rachel Hodan,Linda Rodgers,Sanjeevani Arora,Mev Dominguez–Valentin,Priyanka Kanth,Bryson W. Katona,(unknown),Maegan E. Roberts,Eduardo Vilar,(unknown),Randall E. Brand,Edward D. Esplin,Kimberly Perez	3
11	Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis 2021 ·Cancer Prevention Research ·(unknown),(unknown),Ester Borràs,Wenhui Wu,(unknown),Kyle Chang,Prashant Bommi,Melissa W. Taggart,Selvi Thirumurthi,Patrick M. Lynch,Laura Reyes-Uribe,Paul Scheet,Krishna M. Sinha,Eduardo Vilar	10
12	Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP) 2020 ·Cancer Prevention Research ·(unknown),Praveen Rajendran,Wan Mohaiza Dashwood,(unknown),(unknown),(unknown),Michelle I. Savage,Powel H. Brown,Shizuko Sei,Altaf Mohammed,Eduardo Vilar,Roderick H. Dashwood	12
13	Outcomes of disease-specific next-generation sequencing gene panel testing in adolescents and young adults with colorectal cancer 2019 ·Cancer Genetics ·Maureen E. Mork,(unknown),Sarah A. Bannon,Patrick M. Lynch,Miguel A. Rodrı́guez-Bigas,Selvi Thirumurthi,Y. Nancy You,Eduardo Vilar	2
14	High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer 2018 ·Cancer Prevention Research ·Sarah A. Bannon,Maria F. Montiel,Jennifer B. Goldstein,Wenli Dong,Maureen E. Mork,Ester Borràs,(unknown),Gauri R. Varadhachary,Anirban Maitra,Matthew H. G. Katz,Lei Feng,P. Andrew Futreal,David R. Fogelman,Eduardo Vilar,Florencia McAllister	32
15	In Silico Systems Biology Analysis of Variants of Uncertain Significance in Lynch Syndrome Supports the Prioritization of Functional Molecular Validation 2017 ·Cancer Prevention Research ·Ester Borràs,Kyle Chang,Mala Pande,(unknown),(unknown),Sarah A. Bannon,Maureen E. Mork,Miguel A. Rodrı́guez-Bigas,Melissa W. Taggart,Patrick M. Lynch,Y. Nancy You,Eduardo Vilar	12
16	Can Microsatellite Status of Colorectal Cancer Be Reliably Assessed after Neoadjuvant Therapy? 2017 ·Clinical Cancer Research ·Jennifer B. Goldstein,William Ka Kei Wu,Ester Borràs,(unknown),(unknown),Maureen E. Mork,Sarah A. Bannon,Patrick M. Lynch,Miguel A. Rodrı́guez-Bigas,Melissa W. Taggart,Ji Yuan Wu,Paul Scheet,Scott Kopetz,Y. Nancy You,Eduardo Vilar	30
17	Frameshift mutational target gene analysis identifies similarities and differences in constitutional mismatch repair‐deficiency and Lynch syndrome 2017 ·Molecular Carcinogenesis ·Claudia Maletzki,(unknown),Ingrid Bauer,Tim Ripperger,(unknown),Eduardo Vilar,(unknown),(unknown),Friedrich Prall,Michael Linnebacher	11
18	Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing 2017 ·Nature Medicine ·Miguel Crespo,Eduardo Vilar,Su‐Yi Tsai,Kyle Chang,Sadaf Amin,Tara Srinivasan,Tuo Zhang,Nina H. Pipalia,Huanhuan Joyce Chen,Mavee Witherspoon,Miriam Gordillo,Jenny Xiang,Frederick R. Maxfield,Steven M. Lipkin,Todd Evans,Shuibing Chen	293
19	MRE11 Deficiency Increases Sensitivity to Poly(ADP-ribose) Polymerase Inhibition in Microsatellite Unstable Colorectal Cancers 2011 ·Cancer Research ·Eduardo Vilar,(unknown),Stephanie L. Stenzel,Leon Raskin,Jaeil Ahn,Vı́ctor Moreno,Bhramar Mukherjee,Maria D. Iniesta,Meredith A. Morgan,Gad Rennert,Stephen B. Gruber	117
20	Gene Expression Patterns in Mismatch Repair-Deficient Colorectal Cancers Highlight the Potential Therapeutic Role of Inhibitors of the Phosphatidylinositol 3-Kinase-AKT-Mammalian Target of Rapamycin Pathway 2009 ·Clinical Cancer Research ·Eduardo Vilar,Bhramar Mukherjee,Rork Kuick,Leon Raskin,David E. Misek,Jeremy M. G. Taylor,Thomas J. Giordano,Samir Hanash,Eric R. Fearon,Gad Rennert,Stephen B. Gruber	46

About Eduardo Vilar

Eduardo Vilar is a scholar working on Pathology and Forensic Medicine, Cancer Research and Oncology, having authored 106 papers that have together received 4.8k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (65 papers), Cancer Genomics and Diagnostics (33 papers) and Colorectal Cancer Treatments and Studies (29 papers). The work is most often cited by research in Oncology (2.9k citations), Pathology and Forensic Medicine (1.9k citations) and Cancer Research (1.4k citations). Eduardo Vilar has collaborated with scholars based in United States, Spain and Italy. Frequent co-authors include Stephen B. Gruber, Josep Tabernero, Scott Kopetz, Y. Nancy You, Miguel A. Rodrı́guez-Bigas, José Manuel Pérez-García, Kyle Chang, Cathy Eng, Patrick M. Lynch and Michael J. Overman. Their work appears in journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact